|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,819.90 INR | +1.50% |
|
+1.37% | -17.68% |
| 08/07 | Concord Biotech Limited, Q4 2025 Earnings Call, May 30, 2025 | |
| 02/07 | Stellon Biotech Inc announced that it has received $0.0015 million in funding from Concord Biotech Limited | CI |
EPS & Dividend: Concord Biotech Limited
| Fiscal Period: March | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| Dividend per Share 2 | 8.75 | 10.7 | 10.33 | 13.13 |
| Rate of return | 0.58% | 0.64% | 0.57% | 0.72% |
| EPS 2 | 29.45 | 35.52 | 43.88 | 55.75 |
| Distribution rate | 29.7% | 30.1% | 23.5% | 23.6% |
| Reference price 2 | 1,520.80 | 1,819.90 | 1,819.90 | 1,819.90 |
| Nbr of stocks (in thousands) | 1,04,616 | 1,04,616 | - | - |
| Announcement Date | 24/05/24 | 29/05/25 | - | - |
1INR in Million2INR
Estimates
Past dividends: Concord Biotech Limited
| 21/06/2024 | Annual 8.75 INR |
Upcoming events: Concord Biotech Limited
| 03/09/2025 | Q1 2026 Earnings Release (Projected) |
| 05/11/2025 | Q2 2026 Earnings Release (Projected) |
| 05/02/2026 | Q3 2026 Earnings Release (Projected) |
| 21/05/2026 | Q4 2026 Earnings Release (Projected) |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
| 0.42% | 0.58% | 52.9x | 10.36x | 15.63x | ||
| 1.82% | 2.01% | 26.29x | 4x | 5.55x | ||
| 0.52% | 0.55% | 18.55x | 1.8x | 3.61x | ||
| -.--% | -.--% | 52.07x | 5.86x | 12.57x | ||
| 0.83% | 0.85% | 32.45x | 3x | 4.9x | ||
| -.--% | -.--% | 11.9x | 1.07x | 2.21x | ||
| -.--% | 0.01% | 308.78x | 8.48x | 10.36x | ||
| - | - | 307.3x | 64.31x | 108.29x | ||
| - | - | - | - | - | ||
| -.--% | -.--% | 14.97x | 2.58x | 2.04x | ||
| Average | 0.45% | 0.5% | 91.69x | 11.27x | 18.35x | |
| Weighted average by Cap. | 0.73% | 0.79% | 61.59x | 7.17x | 12.00x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition